PB9673
antibody from Boster Biological Technology
Targeting: NLRC4
CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PB9673 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-CARD12/NLRC4 Antibody Picoband™
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for CARD12/NLRC4 detection. Host: Rabbit.Size: 100μg/vial. Tested applications: WB. Reactive species: Human. CARD12/NLRC4 information: Molecular Weight: 116159 MW; Subcellular Localization: Cytoplasm . Cytoplasm, cytosol . Cytoplasmic filaments; Tissue Specificity: Isoform 2 is expressed ubiquitously, although highly expressed in lung and spleen. Isoform 1 is highly expressed in lung, followed by leukocytes especially monocytes, lymph node, colon, brain, prostate, placenta, spleen, bone marrow and fetal liver. Isoform 4 is only detected in brain.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology.
Tim-3 exacerbates kidney ischaemia/reperfusion injury through the TLR-4/NF-κB signalling pathway and an NLR-C4 inflammasome activation.
He X, Yang W, Zeng Z, Wei Y, Gao J, Zhang B, Li L, Liu L, Wan Y, Zeng Q, Gong Z, Liu L, Zhang H, Li Y, Yang S, Hu T, Wu L, Masliah E, Huang S, Cao H
Cellular & molecular immunology 2020 Mar;17(3):283-299
Cellular & molecular immunology 2020 Mar;17(3):283-299
Tim-3 exacerbates kidney ischaemia/reperfusion injury through the TLR-4/NF-κB signalling pathway and an NLR-C4 inflammasome activation.
Guo Y, Zhang J, Lai X, Chen M, Guo Y
Clinical and experimental immunology 2018 Jul;193(1):113-129
Clinical and experimental immunology 2018 Jul;193(1):113-129
No comments: Submit comment
No validations: Submit validation data